Please use this identifier to cite or link to this item:
10.3389/fpsyt.2023.1112697
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Galmes, Lluis Niell | - |
dc.contributor.author | Rancans, Elmars | - |
dc.date.accessioned | 2023-03-20T10:50:01Z | - |
dc.date.available | 2023-03-20T10:50:01Z | - |
dc.date.issued | 2023-02-24 | - |
dc.identifier.citation | Galmes , L N & Rancans , E 2023 , ' Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum : Real-world evidence from a Spanish hospital setting ' , Frontiers in Psychiatry , vol. 14 , 1112697 . https://doi.org/10.3389/fpsyt.2023.1112697 | - |
dc.identifier.issn | 1664-0640 | - |
dc.identifier.other | PubMedCentral: PMC9998536 | - |
dc.identifier.other | unpaywall: 10.3389/fpsyt.2023.1112697 | - |
dc.identifier.uri | https://dspace.rsu.lv/jspui/handle/123456789/11103 | - |
dc.description | Publisher Copyright: Copyright © 2023 Galmes and Rancans. | - |
dc.description.abstract | Real-world evidence fills in an important gap by providing data on the effectiveness and tolerability of new medications in everyday patients. In this data collection form a Spanish hospital, the effectiveness and tolerability of cariprazine were evaluated in 14 patients who were admitted to the hospital due to an acute episode of schizophrenia or schizoaffective disorder. The collected data included demographic characteristics, history of disorder and previous treatment, and details of cariprazine therapy such as dosing, side effects and measurements of effectiveness via scales. Difference between admission and discharge on the Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression-Severity (CGI-S) scale scores were evaluated using the Wilcoxon Signed-Rank test. Significant improvement was detected in nearly all patients (one patient dropped out) as measured by the BPRS Total, Negative symptom, Positive symptom, and Hostility scores. At admission, patients were markedly-moderately ill and at discharge the severity was reduced to borderline ill and normal according to the CGI-S. The CGI-Improvement scale also indicated very much and much improvement at discharge. Importantly, patients left the hospital with high doses of cariprazine, i.e., 7.5 mg/day or even 9.0 mg/day, but this did not cause safety problems; cariprazine well-tolerated as only a few patients experienced side effects such as akathisia. The results provide novel evidence regarding the tolerability and effectiveness of cariprazine in high doses patients on the schizophrenia spectrum. | en |
dc.format.extent | 531155 | - |
dc.language.iso | eng | - |
dc.relation.ispartof | Frontiers in Psychiatry | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.subject | cariprazine | - |
dc.subject | schizophrenia spectrum | - |
dc.subject | real-world evidence | - |
dc.subject | antipsychotic | - |
dc.subject | partial agonist | - |
dc.subject | high dose antipsychotic treatment | - |
dc.subject | 3.2 Clinical medicine | - |
dc.subject | 1.1. Scientific article indexed in Web of Science and/or Scopus database | - |
dc.subject | General Medicine | - |
dc.title | Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum : Real-world evidence from a Spanish hospital setting | en |
dc.type | /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article | - |
dc.identifier.doi | 10.3389/fpsyt.2023.1112697 | - |
dc.contributor.institution | Department of Psychiatry and Narcology | - |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85150211116&partnerID=8YFLogxK | - |
dc.description.status | Peer reviewed | - |
Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Successful_high_dose_antipsychotic.pdf | 518.71 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.